Latest News and Press Releases

SCOTTSDALE, Ariz., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company's Board of Directors declared a quarter-end cash dividend of $0.10 per issued and outstanding...

Combination Creates a Global Leader in Dermatology Transaction Values Medicis at Approximately $2.6 Billion At Least $225 Million Run Rate in Annual Cost Synergies Expected to be Achieved...

SCOTTSDALE, Ariz., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Second Quarter 2012 Highlights Revenues of approximately $197 million (vs Guidance of $185-$195 million) Non-GAAP Cash EPS of $0.52...

SCOTTSDALE, Ariz., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company expects to report 2012 second quarter financial results after the market closes on Wednesday,...

SCOTTSDALE, Ariz., June 14, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company's Board of Directors declared a quarter-end cash dividend of $0.10 per issued and...

SCOTTSDALE, Ariz., June 5, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Jefferies 2012 Global Healthcare Conference in New York. A live...

SCOTTSDALE, Ariz., June 4, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Goldman Sachs 33rd Annual Global Healthcare Conference in Rancho...

SCOTTSDALE, Ariz., May 14, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Bank of America Merrill Lynch 2012 Health Care Conference in Las...

SCOTTSDALE, Ariz., May 11, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) (the "Company") today announced the pricing of its public offering of $450 million aggregate principal amount of convertible...

SCOTTSDALE, Ariz., May 10, 2012 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) (the "Company") today announced that it intends, subject to market and other conditions, to offer $400 million aggregate...